Asia-Pacific is the largest market of Ibuprofen API with a share of over 30%, the other two main markets are North America and Europe. The top 3 global manufacturers are IOLCP, Biocause, Shandong Xinhua Pharmaceutical.

The global Ibuprofen API market was valued at US$ 606 million in 2020 and is expected to reach US$ 877.9 million by the end of 2027, growing at a CAGR of 5.3% during 2021-2027.
This report focuses on Ibuprofen API volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Ibuprofen API market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Ibuprofen API Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
USP
EP

Segment by Application
Contract Manufacturing Organizations
Pharmaceutical Companies
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
IOLCP
SOLARA
Shandong Xinhua Pharmaceutical
Biocause
BASF
SI Group